Percutaneous nephrostomy - A retrospective study focused on palliative indications

APMIS, Supplement

Volumn 111, Issue 109, 2003, Pages 66-70

  Kinn, Anne Charlotte ^a   Ohlsén, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder cancer; Palliation; Percutaneous nephrostomy; Prostate cancer; Ureteral obstruction

Indexed keywords

ARTICLE; BACKACHE; BLADDER CANCER; BLEEDING; CANCER PATIENT; CONTROLLED STUDY; DEATH; FAMILY; FEVER; FOLLOW UP; HEMATOMA; HUMAN; INFORMED CONSENT; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROLITHIASIS; PALLIATIVE THERAPY; PERCUTANEOUS NEPHROSTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; URETHRA STENOSIS; URINARY DIVERSION; URINOMA; MORTALITY; SURVIVAL RATE;

HUMANS; NEPHROSTOMY, PERCUTANEOUS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0038678089     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Goodwin WE, Casey WC, Woolf W: Percutaneous troacar (needle) nephrostomy in hydronephrosis. J.A.M.A 1955;157:891-894.
2. Jonsson M, Lindberg B, Risholm KL: Percutaneous nephropyelostomy in cases of ureteral obstruction, Scand J Urol Nephrol 1972;6:51-54.
3. Ulmsten U, Molin J: Percutaneous nephropyelostomy in postrenal obstruction. Acta Obstet Gynecol Sacnd 1973; 52 (2):147-151.
4. Almgaard LE, Fernstroem I: Percutaneous nephrostomy. Acta Radiol Diagn 1974;15(3):288-294.
5. Fowler JE, Meares EM, Goodin AR: Percutanoeus Nephrostomy :Technique, indications and results. Urology 1975;6:428-434
6. Hyppolite JC, Daniels ID, Friedman EA: Obstructive uropathy in gynecologic malignancy. Demetrial effect of intraureteral stent placment and vakue of per cutaneous nephrostomy. ASAIO J 1995;41(3):M3 18-23.
7. Desportes L, Blanchet P, Benoit G, Lecouturier S, Langloys J, Decaux A, Di Palma M, Richard C, Jardin A: Neoplastic ureteral obstruction : drainage by percutaneous nephrostomy or double J catheterization. Presse Med 1995;24(29):1332-1336.
8. Mokhmalji H, Braun PM, Martinez Portillo FJ, Siegsmund M, Alken P: Percutaneous nephrostomy versus ureteral stents for diversion caused by stones: a prospective, randomized clinical trial. J Urol 2001;165(4):1088-1092.
9. Lennon GM, Thornhill JA, Grainger R, McDermott TE, Butler MR: Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility. European Urology 1997; 31(1):24-29.
10. Shekarriz B, Shekarriz H, Upadhyay J, Banerjee M, Becker H, Pontes JE, Wood DP Jr: Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 1999;85(4):998-1003.
11. Holden S, McPhee M, Grabstald H:The rationale of urinary diversion in cancer patients. J Urol 1975;121;19-21.
12. Markowitz DM, Wong KT, Laffey KJ, Bixon R, Nagler HM, Martin EC: Maintaining quality of life after palliative diversion for malignant ureteral obstruction. Urol Radiol 1989;11(3):129-132.
13. Ekici S, Sahin A, Ozen H: Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer. J Endourol 2001; 15(8):827-829.
14. Demetriou D, Sebeikat D: Percutaneous nephrostomy in malignant ureteral obstruction. Dtsch Med Wochenschr 1996;12(49):1526-1530.
15. Emmert C, RasslerJ, Kohler U: Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with ter minal cervical cancer. Arch Gynecol Obstet 1997; 259(3): 147-151.